Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.306, 2001-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Amifostine worth extra cost in treating solid tumours
Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. :
Access to resources
Recommend
Tacrolimus worth the extra cost in kidney transplantation
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 310, 2001-01 ,pp. :
Tacrolimus worth the extra cost in kidney transplantation
Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. :
Is Src a Viable Target for Treating Solid Tumours?
Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. :
Acupuncture for chronic headache worth the extra cost to the UK NHS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 450, 2004-01 ,pp. :